These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30081725)

  • 1. Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus, in a mouse model.
    Wang-Lin SX; Zhou C; Kamath AV; Hong K; Koppada N; Saad OM; Carrasco-Triguero M; Khojasteh C; Deng R
    MAbs; 2018 Oct; 10(7):1131-1143. PubMed ID: 30081725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against
    Deng R; Zhou C; Li D; Cai H; Sukumaran S; Carrasco-Triguero M; Saad O; Nazzal D; Lowe C; Ramanujan S; Kamath AV
    MAbs; 2019; 11(6):1162-1174. PubMed ID: 31219754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice.
    Zhou C; Lehar S; Gutierrez J; Rosenberger CM; Ljumanovic N; Dinoso J; Koppada N; Hong K; Baruch A; Carrasco-Triguero M; Saad O; Mariathasan S; Kamath AV
    MAbs; 2016; 8(8):1612-1619. PubMed ID: 27653831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Tissue Distribution, Catabolism, and Elimination of an Anti-
    Cai H; Yip V; Lee MV; Wong S; Saad O; Ma S; Ljumanovic N; Khojasteh SC; Kamath AV; Shen BQ
    Drug Metab Dispos; 2020 Nov; 48(11):1161-1168. PubMed ID: 32839277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging.
    Zhou C; Cai H; Baruch A; Lewin-Koh N; Yang M; Guo F; Xu D; Deng R; Hazenbos W; Kamath AV
    PLoS One; 2019; 14(10):e0224096. PubMed ID: 31661493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-
    Peck M; Rothenberg ME; Deng R; Lewin-Koh N; She G; Kamath AV; Carrasco-Triguero M; Saad O; Castro A; Teufel L; Dickerson DS; Leonardelli M; Tavel JA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910894
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics.
    Sukumaran S; Zhang C; Leipold DD; Saad OM; Xu K; Gadkar K; Samineni D; Wang B; Milojic-Blair M; Carrasco-Triguero M; Rubinfeld B; Fielder P; Lin K; Ramanujan S
    AAPS J; 2017 Jan; 19(1):130-140. PubMed ID: 27679517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections.
    Mariathasan S; Tan MW
    Trends Mol Med; 2017 Feb; 23(2):135-149. PubMed ID: 28126271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data.
    Li C; Zhang C; Deng R; Leipold D; Li D; Latifi B; Gao Y; Zhang C; Li Z; Miles D; Chen SC; Samineni D; Wang B; Agarwal P; Lu D; Prabhu S; Girish S; Kamath AV
    Clin Transl Sci; 2019 Sep; 12(5):534-544. PubMed ID: 31115997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections.
    Stagg NJ; Katavolos P; Achilles Poon K; Zhong S; Ljumanovic N; Kamath A; Cai H; Carrasco-Triguero M; Halpern W
    Toxicol Appl Pharmacol; 2022 Jan; 435():115811. PubMed ID: 34896194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
    Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
    J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model.
    Zhao J; Cao Y; Jusko WJ
    Pharm Res; 2015 Oct; 32(10):3269-81. PubMed ID: 25939552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates.
    Sukumaran S; Gadkar K; Zhang C; Bhakta S; Liu L; Xu K; Raab H; Yu SF; Mai E; Fourie-O'Donohue A; Kozak KR; Ramanujan S; Junutula JR; Lin K
    Pharm Res; 2015 Jun; 32(6):1884-93. PubMed ID: 25446772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice.
    Chang HP; Li Z; Shah DK
    Pharm Res; 2022 Jan; 39(1):1-24. PubMed ID: 35044590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.
    Singh AP; Shin YG; Shah DK
    Pharm Res; 2015 Nov; 32(11):3508-25. PubMed ID: 25666843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
    Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
    PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Pharmacokinetic Model-Informed Drug Development for Polatuzumab Vedotin: Label for Drug-Drug Interactions Without Dedicated Clinical Trials.
    Samineni D; Ding H; Ma F; Shi R; Lu D; Miles D; Mao J; Li C; Jin J; Wright M; Girish S; Chen Y
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S120-S131. PubMed ID: 33205435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.
    Kågedal M; Gibiansky L; Xu J; Wang X; Samineni D; Chen SC; Lu D; Agarwal P; Wang B; Saad O; Koppada N; Fine BM; Jin JY; Girish S; Li C
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):537-548. PubMed ID: 28918591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
    Lehar SM; Pillow T; Xu M; Staben L; Kajihara KK; Vandlen R; DePalatis L; Raab H; Hazenbos WL; Morisaki JH; Kim J; Park S; Darwish M; Lee BC; Hernandez H; Loyet KM; Lupardus P; Fong R; Yan D; Chalouni C; Luis E; Khalfin Y; Plise E; Cheong J; Lyssikatos JP; Strandh M; Koefoed K; Andersen PS; Flygare JA; Wah Tan M; Brown EJ; Mariathasan S
    Nature; 2015 Nov; 527(7578):323-8. PubMed ID: 26536114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.